Press release – Grenoble, October 11, 2024
Xenocs is pleased to announce a strategic commercial agreement with Sinopharm, a leading healthcare and pharmaceutical distribution company in China. This partnership will significantly enhance the accessibility of advanced analytical solutions for China’s rapidly growing pharmaceutical industry.
This collaboration brings together two industry leaders, leveraging Sinopharm’s extensive distribution network across China to deliver Xenocs’ cutting-edge X-ray scattering technology to industrial pharmaceutical researchers and developers nationwide.
“Partnering with Sinopharm is a significant milestone for Xenocs,” said Frédéric Bossan, Managing Director of Xenocs. “This collaboration allows us to expand our reach into the pharmaceutical industry sector in China, where we can make a real impact in drug development processes. Our innovative solutions will empower laboratories and enhance research efficiency, ultimately benefiting the healthcare landscape in China.”
LIN Hong, Executive Officer of Sinopharm (Shanghai) Medical Device Supply Chain Co.,Ltd, added, “We are thrilled to partner with Xenocs, as their advanced product offerings complement our mission to provide top-tier healthcare solutions. This partnership will not only improve access to critical technologies for pharmaceutical companies but also drive innovation within the industry. Together, we are committed to supporting the growth and development of China’s pharmaceutical sector.”
About Sinopharm
Sinopharm, one of the largest pharmaceutical and healthcare distribution companies in China, operates within a comprehensive network that includes manufacturing, distribution, and retailing. With a mission to provide quality healthcare solutions, Sinopharm has established itself as a trusted partner to healthcare professionals and organizations. The company actively promotes public health through the distribution of pharmaceuticals, medical devices, and health products across the country, thereby enhancing access to essential healthcare resources for millions.
About Xenocs
Xenocs is a global leader in nanoscale characterization solutions.With over 24 years of expertise, the company offers high-performance instruments and software based on Small and Wide Angle X-ray Scattering (SAXS/WAXS) and imaging techniques. From enhancing drug development processes to optimizing nanomaterials for sustainable energy, by providing precise analytical capabilities, Xenocs supports scientific breakthroughs across academia and industry. The company measures its success not just in technological advancements but in the achievements of the researchers and innovators who depend on its solutions every day.
For more information, visit www.xenocs.com and follow us on Linkedin.
